SCHEMBL10048474

SCHEMBL10048474

CC1(C)c2cccc(P(C(C)(C)C)C(C)(C)C)c2Oc2c(P3C(C)(C)CC3(C)C)cccc21

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29883736 0.85 DRD1 (0.58) DRD1
SCHEMBL29589463 0.85 DRD1 (0.58) DRD1
SCHEMBL1315091 0.85 DRD1 (0.58) DRD1
SCHEMBL15883111 0.78 DRD1 (0.51) DRD1
SCHEMBL24535251 0.74 DRD1 (0.40) DRD1
SCHEMBL24535274 0.73 DRD1 (0.41) DRD1
SCHEMBL709261 0.67 DRD1 (0.64) DRD1
SCHEMBL29867522 0.67 DRD1 (0.64) DRD1
SCHEMBL16987374 0.67 DRD1 (0.51) DRD1
SCHEMBL21374252 0.66 DRD1 (0.62) DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120140439-A1 RARE-EARTH COMPLEX AND USES THEREOF National University Corporation NARA Institute of Science and Technology (JP) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120140439-A1 RARE-EARTH COMPLEX AND USES THEREOF LUC7L2, NDUFS5, NDUFS7 DRD1 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.